4.7 (687) In stock
Malignant mesothelioma (MM) is an aggressive tumor with a dismal prognosis, and the molecular alterations involved in this disease remain unknown. We previously reported that microRNA-34s (miR-34s) are methylated and downregulated in MM and may play an important role in the carcinogenesis of MM. In this study, we downregulated miR-34s in human mesothelial cells to investigate the cellular effect of miR-34 knockdown. For the cell study, we used LP-9, a human mesothelial cell line, and three human primary-cultured mesothelial cell lines. RNA-based miR-34a, -34b and -34c inhibitors were transfected into these cells, and their effects on proliferation and invasion were evaluated. A scramble RNA oligonucleotide was used as a control. The protein expression status was estimated using western blotting. After miR-34 inhibitor transfection, miR-34a, -34b and -34c were downregulated in all the examined mesothelial cell lines. miR-34 inhibitor transfection significantly increased cell proliferation in all of the mesothelial cell lines, compared with the scramble control. The invasive ability also increased in the miR-34 inhibitor transfectants, compared with the scramble control, in the LP-9 cell line. Western blotting confirmed the upregulation of c-MET, phospho-c-MET, and bcl-2 proteins in LP-9 cells after miR-34 inhibitor transfection. In conclusion, our study showed that the downregulation of miR-34s induced an oncogenic phenotype in non-malignant mesothelial cells. The present study, together with the results of our previous report, strongly suggest that miR-34s play an important role in the early carcinogenic process involved in the transformation of human mesothelial cells to MM.
MicroRNA in pancreatic cancer
Epigenetic Regulation of miRNA Expression in Malignant Mesothelioma: miRNAs as Biomarkers of Early Diagnosis and Therapy. - Abstract - Europe PMC
IJERPH, Free Full-Text
PDF) Abstract 187: Down-regulation of microRNA34 induces cell
miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive
Biomedicines, Free Full-Text
Frontiers MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review
Frontiers Approaches Toward Targeting Matrix Metalloproteases
Cureus Exploring Tumor-Promoting Qualities of Cancer-Associated
Biomedicines, Free Full-Text
MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets - Reid - Journal of Thoracic Disease
Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma - ScienceDirect
miR-200b/c attenuates lipopolysaccharide-induced early pulmonary